0

NNGH

INQUIRY Add to cart
For Research Use Only | Not For Clinical Use
CATAP161314176-B
CAS161314-17-6
Structure
MDL NumberMFCD02179370
Molecular Weight316.37
InChI KeyJIRXORZYIXSWOB-UHFFFAOYSA-N
Description≥98% (HPLC)
SolubilityDMSO: 15 mg/mL, clear
Assay≥98% (HPLC)
Colorwhite to beige
Formpowder
Size5MG, 25MG
Storage Conditions2-8°C
1

Catalytic Domain of MMP20 (Enamelysin) - The NMR Structure of a New Matrix Metalloproteinase

Yvonne Arendt, Lucia Banci, Ivano Bertini, Francesca Cantini, Roberta Cozzi, Rebecca Del Conte, Leonardo Gonnelli

FEBS Lett. 2007 Oct 2;581(24):4723-6.

PMID: 17869250

1

Comparison of the Effects of Matrix Metalloproteinase Inhibitors on TNF-α Release From Activated Microglia and TNF-α Converting Enzyme Activity

Eun-Jung Lee, Pyong-Gon Moon, Moon-Chang Baek, Hee-Sun Kim

Biomol Ther (Seoul). 2014 Sep;22(5):414-9.

PMID: 25414771

1

First Insight Into Structure-Activity Relationships of Selective Meprin β Inhibitors

Daniel Ramsbeck, Antje Hamann, Dagmar Schlenzig, Stephan Schilling, Mirko Buchholz

Bioorg Med Chem Lett. 2017 Jun 1;27(11):2428-2431.

PMID: 28408220

1

MMP3 Activity Rather Than Cortical Stiffness Determines NHE1-dependent Invasiveness of Melanoma Cells

Dennis Keurhorst, Ivan Liashkovich, Fabian Frontzek, Svenja Nitzlaff, Verena Hofschröer, Rita Dreier, Christian Stock

Cancer Cell Int. 2019 Nov 9;19:285.

PMID: 31728131

1

Structure-based Approach to Nanomolar, Water Soluble Matrix Metalloproteinases Inhibitors (MMPIs)

Emanuele Attolino, Vito Calderone, Elisa Dragoni, Marco Fragai, Barbara Richichi, Claudio Luchinat, Cristina Nativi

Eur J Med Chem. 2010 Dec;45(12):5919-25.

PMID: 20965620

  • Verification code
Contact Us

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.
Online Inquiry

Online Inquiry

For any inquiry, question or recommendation, please call: or fill out the following form.

  • Verification code

Head Office

  • Tel:
  • Email:

Follow us on

qrcode